U.S. market Closed. Opens in 19 hours 21 minutes

BCDAW | BioCardia, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue477.00K1.35M1.01M145.00K710.00K
Cost of Revenue7.73M11.90M640.00K4.00K358.00K
Gross Profit-7.25M-10.55M375.00K141.00K352.00K
Operating Expenses12.12M13.25M13.64M15.67M14.56M
Selling, General & Admin4.39M4.42M5.09M5.86M6.00M
Research & Development7.73M8.83M8.56M9.81M8.56M
Other Operating ExpensesN/A-6.00K-2.00K-2.00K-2.00K
Operating Income-11.64M-11.90M-12.63M-15.53M-14.21M
Other Expenses / Income73.00K-6.00K7.00K525.00K-496.00K
Before Tax Income-11.57M-11.91M-12.62M-15.00M-14.71M
Income Tax ExpensesN/A6.00K-2.00K1.00K110.00K
Net Income-11.57M-11.91M-12.62M-15.01M-14.82M
Interest ExpensesN/A6.00KN/A3.00K112.00K
Basic Shares Outstanding1.41M1.18M1.13M674.58K376.29K
Diluted Shares Outstanding1.41M1.18M1.13M674.58K376.29K
EBITDA-11.56M-11.82M-12.57M-14.44M-14.05M
EBITDA Margin-2,423.48%-874.19%-1,238.42%-9,955.17%-1,978.31%
EBIT-11.57M-11.90M-12.62M-15.00M-14.60M
EBIT Margin-2,425.79%-880.25%-1,243.65%-10,345.52%-2,055.92%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙